ReNerve Partners with Collagen Solutions for Nerve Graft Manufacturing
ReNerve Ltd (ReNerve) today announced that it has partnered with Collagen Solutions, LLC for the development and commercial scale contract… Read more
ReNerve and 3DBioFibR partner for ‘bionic’ nerve project
ReNerve Ltd (ReNerve) today announced that it has partnered with 3D BioFibR to further develop its ‘bionic nerve project’. The… Read more
ReNerve End of Year Company update
ReNerve is pleased to provide you with this end of year Company Update for 2022
ReNerve Shareholder Newsletter Oct 2022
“Surgeons have commented very favourably on the Cuff’s key characteristics (particularly its ease of handling, pliability and bio-absorption) by comparison… Read more
ReNerve AGM Company Update Oct 2022
“We have not seen any real advancement in nerve repair and replacements in 20 years. ReNerve has a real opportunity… Read more
NervAlign® Nerve Cuff first sale and case in the US
“This is an important commercial milestone for the company as it begins to roll out its Nerve Cuff product in… Read more
FDA Clearance for NervAlign® Nerve Cuff
11th of February 2022: Melbourne Australia: ReNerve Ltd today announced it has received market clearance from the FDA for its… Read more
RENERVE NEWSLETTER December 2021
ReNerve has made considerable progress over the past twelve months. ReNerve is well capitalised, optimistic that they will be able… Read more
